ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01583608
Recruitment Status : Completed
First Posted : April 24, 2012
Last Update Posted : December 9, 2016
Abbott Vascular
Information provided by (Responsible Party):
Detlef Mathey, Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : June 2016